Safety of Immunomodulatory Systemic Therapies Used in the Management of Immune-Related Cutaneous Adverse Events
SL Gu, S Nath, A Markova - Pharmaceuticals, 2023 - mdpi.com
Immune-related cutaneous adverse events (ircAEs) commonly occur in patients on treatment
with immune checkpoint inhibitors and can significantly reduce patient quality of life. These …
with immune checkpoint inhibitors and can significantly reduce patient quality of life. These …
Tumor Microenvironment Heterogeneity, Potential Therapeutic Avenues, and Emerging Therapies
X Peng, J Zheng, T Liu, Z Zhou, C Song… - Current Cancer Drug …, 2024 - ingentaconnect.com
Objective: This review describes the comprehensive portrait of tumor microenvironment
(TME). Additionally, we provided a panoramic perspective on the transformation and …
(TME). Additionally, we provided a panoramic perspective on the transformation and …
Molecular characterization analysis of PANoptosis-related genes in colorectal cancer based on bioinformatic analysis
M Zhang, W Li, Y Zhao, L Qi, Y Xiao, D Liu, TL Peng - PloS one, 2024 - journals.plos.org
Colorectal cancer (CRC) ranks as the third most prevalent cancer globally and stands as the
second principal contributor to cancer-related fatalities. Recently, emerging research has …
second principal contributor to cancer-related fatalities. Recently, emerging research has …
An analysis pipeline for understanding 6-thioguanine effects on a mouse tumour genome
P Yankilevich, L Nazerai, SC Willis… - Cancer Immunology …, 2024 - Springer
Mouse tumour models are extensively used as a pre-clinical research tool in the field of
oncology, playing an important role in anticancer drugs discovery. Accordingly, in cancer …
oncology, playing an important role in anticancer drugs discovery. Accordingly, in cancer …